SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Sol-Gel Technologies (SLGL) — Dec 29, 2017

Sol-Gel Technologies Ltd.
Date: Dec. 29, 2017 · CIK: 0001684693 · Accession: 0001571049-17-008775

AI Filing Summary & Sentiment

Referenced dates: September 11, 2017

Date
Dec. 29, 2017
Author
Assistant Director
Form
CORRESP
Company
Sol-Gel Technologies Ltd.

Letter

VIA EDGAR AND HAND DELIVERY Division of Corporation Finance Washington, D.C. 20549 Re: Sol-Gel Technologies Ltd. Registration Statement on Form F-1 (CIK No. 0001684693)

Dear Ms. Hayes:

On behalf of Sol-Gel Technologies Ltd. (the “Company”), we are transmitting this letter in response to the comment received from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) by letter dated September 11, 2017 with respect to the Company’s Registration Statement on Form F-1 (the “Registration Statement”). This letter is being submitted together with a copy of Amendment No. 3 to the Registration Statement on Form F-1, which was filed on EDGAR on December 29, 2017 and revises the Registration Statement to address the Staff’s comment (the “Amended Registration Statement”). The bold and numbered paragraph below corresponds to the numbered paragraph in the Staff’s letter and is followed by the Company’s response. For the Staff’s convenience, we are also sending, by courier, copies of this letter and marked copies of the Amended Registration Statement that reflect changes made to the Registration Statement.

Prospectus

Pages 2 and 81

1. Please revise your added disclosure on page 2 and 81 to remove the reference to “favorable safety profile.” A safety determination is exclusively a FDA determination.

December 29, 2017

Page 2

Response: The Company acknowledges the Staff’s comment and has revised the disclosure in the Amended Registration Statement on pages 2 and 81.

If you have any questions regarding the foregoing response or the enclosed Amended Registration Statement, please do not hesitate to contact me by telephone at (212) 906-2916.

Very truly yours,
/s/ Nathan Ajiashvili

Show Raw Text
CORRESP
1
filename1.htm

    53rd
    at Third

    885
    Third Avenue

    New
    York, New York 10022-4834

    Tel:
    +1.212.906.1200 Fax: +1.212.751.4864

    www.lw.com

    FIRM
    / AFFILIATE OFFICES

    Barcelona
    Moscow

    Beijing
    Munich

    Boston
    New York

    Brussels
    Orange County

    Century City
    Paris

    Chicago
    Riyadh

    Dubai
    Rome

    Düsseldorf
    San Diego

    Frankfurt
    San Francisco

    December 29, 2017
    Hamburg
    Seoul

    Hong Kong
    Shanghai

    Houston
    Silicon Valley

    London
    Singapore

    Los Angeles
    Tokyo

    Madrid
    Washington, D.C.

    Milan

VIA EDGAR AND HAND DELIVERY

Ms. Suzanne Hayes

Assistant Director

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E

Washington, D.C. 20549

 Re: Sol-Gel Technologies Ltd.

Registration Statement on Form
F-1

(CIK No. 0001684693)

Dear Ms. Hayes:

On behalf of Sol-Gel Technologies Ltd.
(the “Company”), we are transmitting this letter in response to the comment received from the staff
(the “Staff”) of the Securities and Exchange Commission (the “Commission”)
by letter dated September 11, 2017 with respect to the Company’s Registration Statement on Form F-1 (the “Registration
Statement”). This letter is being submitted together with a copy of Amendment No. 3 to the Registration Statement
on Form F-1, which was filed on EDGAR on December 29, 2017 and revises the Registration Statement to address
the Staff’s comment (the “Amended Registration Statement”). The bold and numbered paragraph below
corresponds to the numbered paragraph in the Staff’s letter and is followed by the Company’s response. For the Staff’s
convenience, we are also sending, by courier, copies of this letter and marked copies of the Amended Registration Statement that
reflect changes made to the Registration Statement.

Prospectus

Pages 2 and 81

 1. Please revise your added disclosure on page 2 and 81 to remove the reference to “favorable safety
profile.” A safety determination is exclusively a FDA determination.

December
29, 2017

Page 2

Response: The Company acknowledges the Staff’s
comment and has revised the disclosure in the Amended Registration Statement on pages 2 and 81.

If you have any questions regarding
the foregoing response or the enclosed Amended Registration Statement, please do not hesitate to contact me by telephone at (212)
906-2916.

    Very truly yours,

    /s/ Nathan Ajiashvili

    Nathan Ajiashvili

    of LATHAM & WATKINS LLP

 cc: Alon Seri-Levy, Chief Executive Officer, Sol-Gel Technologies
Ltd.

Joshua Kiernan, Latham & Watkins
LLP

Gene Kleinhendler, Gross, Kleinhendler,
Hodak, Halevy, Greenberg & Co.